CXCL5 and gastric cancer: Blockade of CXCL5 by neutralizing antibody inhibited the phosphorylation of ERK by TTCM in GC cells and inhibition of ERK decreased the promotion of GC cell migration and invasion by TTCM (Fig. 3d, e).